Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|48|2|210-220

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.48, Iss.2, 2018-02, pp. : 210-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2770-2770

John Wiley & Sons Inc

Access to resources Recommend Favorite

An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab

By  

TRANSFUSION, Vol. 55, Iss. 9, 2015-09 ,pp. : 2292-2293

John Wiley & Sons Inc

Access to resources Recommend Favorite

An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab

By  

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2292-2293

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lymphomatoid Granulomatosis in a Patient with Rheumatoid Arthritis Receiving Methotrexate: Successful Treatment with the Anti-CD20 Antibody Mabthera

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 440-441

Karger

Access to resources Recommend Favorite

Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)

By  

Respiration, Vol. 78, Iss. 1, 2008-09 ,pp. : 106-109

Karger

Access to resources Recommend Favorite